Globus Medical, Inc. (GMED)

Globus Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	586.71	537.87	102.98	122.87	190.17	149.19
Depreciation & Amortization	281.05	276.84	253.39	145.53	68.25	69.87
Stock-Based Compensation	49.19	49.78	54.19	52.74	32.81	30.59
Other Adjustments	-40.29	-44.25	207.63	38.96	-7.5	43.88
Change in Receivables	-88.18	-52.18	-78.06	-49.91	-50.84	-25.9
Changes in Inventories	-26.66	-17.6	-29.86	-70.33	-61.75	-11.97
Changes in Accounts Payable	14.47	8.49	17.66	-14.22	14.42	3.68
Changes in Accrued Expenses	38.21	34.22	5.02	17.13	6.09	17.9
Changes in Income Taxes Payable	-55.88	-50.85	-13.38	-0.41	-2.89	5.21
Changes in Other Operating Activities	13.54	11.13	1.06	1.15	-10.29	-6.18
Operating Cash Flow	778.51	753.45	520.64	243.5	178.47	276.27
Operating Cash Flow Growth	20.60%	44.72%	113.81%	36.44%	-35.40%	38.98%
Capital Expenditures	-168.19	-164.68	-115.43	-78.27	-74.05	-56.9
Purchases of Intangible Assets	-7.25	-9.75	-	-	-	-
Purchases of Investments	-252.17	-107.53	-113.5	-100.64	-419.53	-622.36
Proceeds from Sale of Investments	100.61	179.49	70.52	777.91	414.65	337.81
Payments for Business Acquisitions	-252.46	-252.55	-17.64	-296.03	-31.44	-34.49
Investing Cash Flow	-669.07	-355.01	-176.05	302.97	-110.36	-375.94
Long-Term Debt Repaid	-	-449.99	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-449.99	-	-	-	-
Issuance of Common Stock	104.5	89.76	110.44	12.4	41.72	63.5
Repurchase of Common Stock	-114.06	-303.36	-92.52	-236.18	-144.49	-
Net Common Stock Issued (Repurchased)	-9.56	-213.6	17.92	-223.78	-102.78	63.5
Other Financing Activities	-16.01	-15.57	-45.62	-8.04	-7.19	-9.35
Financing Cash Flow	-25.57	-679.16	-27.7	-231.82	-109.96	54.15
Effect of Exchange Rate Changes on Cash and Cash Equivalents	15.81	22.45	0.26	2.18	-0.75	-0.81
Net Cash Flow	99.68	-258.28	317.15	316.83	-42.6	-46.33
Free Cash Flow	610.32	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Growth	3.66%	45.30%	145.25%	58.23%	-52.40%	62.34%
FCF Margin	19.68%	20.03%	16.08%	10.53%	10.21%	22.90%
Free Cash Flow Per Share	4.47	4.30	2.94	1.44	1.02	2.12
Levered Free Cash Flow	683.23	185.43	221.45	123.44	129.96	170.8
Unlevered Free Cash Flow	571.61	524.08	260.07	99.48	118.16	163.81

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q